Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Adolescent Obesity

3,4-methylenedioxyamphetamine has been researched along with Adolescent Obesity in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sirico, F1
Fernando, F1
Bianco, A1
Loiacono, C1
Nuccio, F1
Gambardella, F1
Palermi, S1
Montagnani, S1
Biffi, A1
Gregori, D1
Hochdorn, A1
Azzolina, D1
Berchialla, P1
Lorenzoni, G1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Adolescent Obesity

ArticleYear
Parental Perception of Children's Weight Status: Love Overpasses Scientific Evidence! A Cross-Sectional Observational Study.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2020, Volume: 27, Issue:1

    Topics: Adolescent; Adolescent Development; Age Factors; Body Mass Index; Child; Child Development; Child, P

2020
Does Love Really Make Mothers Blind? A Large Transcontinental Study on Mothers' Awareness About Their Children's Weight.
    Obesity (Silver Spring, Md.), 2018, Volume: 26, Issue:7

    Topics: Adult; Attitude to Health; Awareness; Body Mass Index; Body Weight; Child; Child, Preschool; Cross-S

2018